DK1263790T3 - Monoklonale antistoffer for den humane LDL-receptor, deres produktionsmetode og anvendelse - Google Patents

Monoklonale antistoffer for den humane LDL-receptor, deres produktionsmetode og anvendelse

Info

Publication number: DK1263790T3
Authority: DK; Denmark
Prior art keywords: production method; monoclonal antibodies; ldl receptor; human ldl; human
Prior art date: 2000-03-13

Application number

DK01912086T

Other languages

English (en)

Inventor

Moshe Smolarsky

Francesco Antonetti

Michel Dreano

Nachum Yonah

Dany Suissa

Ilana Belzer

Original Assignee

Applied Research Systems

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-13

Filing date

2001-03-08

Publication date

2007-07-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26323933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1263790(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-03-13 Priority claimed from IL13502500A external-priority patent/IL135025A0/xx

2001-03-08 Application filed by Applied Research Systems filed Critical Applied Research Systems

2007-07-02 Application granted granted Critical

2007-07-02 Publication of DK1263790T3 publication Critical patent/DK1263790T3/da

Links

101001051093 Homo sapiens Low-density lipoprotein receptor Proteins 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Virology (AREA)
Veterinary Medicine (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Communicable Diseases (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Biotechnology (AREA)
Engineering & Computer Science (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

DK01912086T 2000-03-13 2001-03-08 Monoklonale antistoffer for den humane LDL-receptor, deres produktionsmetode og anvendelse DK1263790T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IL13502500A IL135025A0 (en)	2000-03-13	2000-03-13	Monoclonal antibodies to the human ldl receptor, their production and use
IL13921700A IL139217A0 (en)	2000-03-13	2000-10-23	Monoclonal antibodies to the human ldl receptor, their production and use
PCT/IL2001/000216 WO2001068710A1 (en)	2000-03-13	2001-03-08	Monoclonal antibodies to the human ldl receptor, their production and use

Publications (1)

Publication Number	Publication Date
DK1263790T3 true DK1263790T3 (da)	2007-07-02

Family

ID=26323933

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01912086T DK1263790T3 (da)	2000-03-13	2001-03-08	Monoklonale antistoffer for den humane LDL-receptor, deres produktionsmetode og anvendelse

Country Status (32)

Country	Link
US (1)	US6849720B2 (da)
EP (1)	EP1263790B1 (da)
JP (1)	JP4768193B2 (da)
KR (1)	KR100882081B1 (da)
CN (1)	CN1418225B (da)
AR (1)	AR028518A1 (da)
AT (1)	ATE362490T1 (da)
AU (2)	AU4100201A (da)
BG (1)	BG65762B1 (da)
BR (1)	BR0109164A (da)
CA (1)	CA2402593C (da)
CY (1)	CY1108020T1 (da)
CZ (1)	CZ20023098A3 (da)
DE (1)	DE60128452T2 (da)
DK (1)	DK1263790T3 (da)
EA (1)	EA007494B1 (da)
EE (1)	EE200200517A (da)
ES (1)	ES2282238T3 (da)
HR (1)	HRP20020704B1 (da)
HU (1)	HU226194B1 (da)
IL (2)	IL139217A0 (da)
MX (1)	MXPA02009091A (da)
NO (1)	NO330904B1 (da)
NZ (1)	NZ520944A (da)
PL (1)	PL206041B1 (da)
PT (1)	PT1263790E (da)
RS (1)	RS51406B (da)
SI (1)	SI1263790T1 (da)
SK (1)	SK287348B6 (da)
UA (1)	UA78489C2 (da)
WO (1)	WO2001068710A1 (da)
ZA (1)	ZA200206654B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0114629D0 (en) *	2001-06-15	2001-08-08	Pfizer Ltd	Method
CA2525517C (en)	2003-06-19	2016-05-31	Applied Research Systems Ars Holding N.V.	Use of prion conversion modulating agents
FR2889532B1 (fr) *	2005-08-03	2007-10-12	Lab Francais Du Fractionnement	Anticorps diriges contre le recepteur du ldl
FR2889533B1 (fr) *	2005-08-03	2007-10-12	Lab Francais Du Fractionnement	Anticorps diriges contre le recepteur du ldl
EP1991869A2 (en) *	2006-02-17	2008-11-19	Paolo La Colla	Methods for the diagnosis of proliferative and/or conformational diseases
FR2910896B1 (fr) *	2006-12-29	2012-11-16	Lab Francais Du Fractionnement	Anticorps monoclonal dirige contre le recepteur humain des ldl
IL182956A0 (en)	2007-05-03	2008-01-20	Yeda Res & Dev	Glycan modified soluble receptors and binding proteins and their use
IL188628A0 (en) *	2008-01-07	2008-12-29	Yeda Res & Dev	Use of soluble ldl-r for viral hepatitis
GB0922377D0 (en) *	2009-12-22	2010-02-03	Arab Gulf University The	Mutant LDL receptor
CN103429265A (zh)	2010-05-25	2013-12-04	国家医疗保健研究所	用于治疗和预防hcv感染的抗包膜抗体和抗受体抗体组合物
WO2013024155A1 (en)	2011-08-17	2013-02-21	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Combinations of anti-hcv-entry factor antibodies and direct acting antivirals for the treatment and the prevention of hcv infection
WO2013024156A2 (en)	2011-08-17	2013-02-21	INSERM (Institut National de la Santé et de la Recherche Médicale)	Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
WO2013024157A2 (en)	2011-08-17	2013-02-21	INSERM (Institut National de la Santé et de la Recherche Médicale)	Combinations of host targeting agents for the treatment and the prevention of hcv infection
CN103111270B (zh) *	2013-02-26	2015-06-10	王业富	一种乙型肝炎抗原蛋白的吸附材料及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5182364A (en) *	1990-02-26	1993-01-26	The Scripps Research Institute	Polypeptide analogs of apolipoprotein E
US5496926A (en) *	1992-01-19	1996-03-05	Yeda Research And Development Co. Ltd.	Process of preparing a soluble LDL receptor
US5945308A (en) *	1998-04-03	1999-08-31	Incyte Pharmaceuticals, Inc.	Human oxidized LDL receptor
JP2000279174A (ja) *	1999-03-30	2000-10-10	Bml Inc	ヒトｌｄｌレセプターに対するモノクローナル抗体及びこれを用いる家族性高脂血症の判定方法

2000
- 2000-10-23 IL IL13921700A patent/IL139217A0/xx unknown
2001
- 2001-03-08 SI SI200130736T patent/SI1263790T1/sl unknown
- 2001-03-08 AT AT01912086T patent/ATE362490T1/de active
- 2001-03-08 EP EP01912086A patent/EP1263790B1/en not_active Expired - Lifetime
- 2001-03-08 DE DE60128452T patent/DE60128452T2/de not_active Expired - Lifetime
- 2001-03-08 SK SK1312-2002A patent/SK287348B6/sk not_active IP Right Cessation
- 2001-03-08 PT PT01912086T patent/PT1263790E/pt unknown
- 2001-03-08 KR KR1020027011767A patent/KR100882081B1/ko not_active Expired - Fee Related
- 2001-03-08 IL IL15171301A patent/IL151713A0/xx not_active IP Right Cessation
- 2001-03-08 EE EEP200200517A patent/EE200200517A/xx unknown
- 2001-03-08 DK DK01912086T patent/DK1263790T3/da active
- 2001-03-08 US US10/221,679 patent/US6849720B2/en not_active Expired - Fee Related
- 2001-03-08 AU AU4100201A patent/AU4100201A/xx active Pending
- 2001-03-08 WO PCT/IL2001/000216 patent/WO2001068710A1/en active IP Right Grant
- 2001-03-08 MX MXPA02009091A patent/MXPA02009091A/es active IP Right Grant
- 2001-03-08 BR BR0109164-6A patent/BR0109164A/pt not_active Application Discontinuation
- 2001-03-08 HR HR20020704A patent/HRP20020704B1/xx not_active IP Right Cessation
- 2001-03-08 JP JP2001567800A patent/JP4768193B2/ja not_active Expired - Fee Related
- 2001-03-08 PL PL358381A patent/PL206041B1/pl unknown
- 2001-03-08 EA EA200200974A patent/EA007494B1/ru not_active IP Right Cessation
- 2001-03-08 RS YUP-686/02A patent/RS51406B/sr unknown
- 2001-03-08 CA CA2402593A patent/CA2402593C/en not_active Expired - Fee Related
- 2001-03-08 HU HU0300142A patent/HU226194B1/hu not_active IP Right Cessation
- 2001-03-08 CZ CZ20023098A patent/CZ20023098A3/cs unknown
- 2001-03-08 AU AU2001241002A patent/AU2001241002B8/en not_active Ceased
- 2001-03-08 ES ES01912086T patent/ES2282238T3/es not_active Expired - Lifetime
- 2001-03-08 NZ NZ520944A patent/NZ520944A/en not_active IP Right Cessation
- 2001-03-08 CN CN018065740A patent/CN1418225B/zh not_active Expired - Fee Related
- 2001-03-12 AR ARP010101148A patent/AR028518A1/es active IP Right Grant
- 2001-08-03 UA UA2002108101A patent/UA78489C2/uk unknown
2002
- 2002-08-20 ZA ZA200206654A patent/ZA200206654B/en unknown
- 2002-09-04 NO NO20024223A patent/NO330904B1/no not_active IP Right Cessation
- 2002-09-05 BG BG107063A patent/BG65762B1/bg unknown
2007
- 2007-07-13 CY CY20071100939T patent/CY1108020T1/el unknown

Also Published As

Publication number	Publication date
BR0109164A (pt)	2002-11-26
CN1418225B (zh)	2012-04-18
NO330904B1 (no)	2011-08-15
EP1263790A1 (en)	2002-12-11
WO2001068710A1 (en)	2001-09-20
AU2001241002B2 (en)	2006-04-06
ES2282238T3 (es)	2007-10-16
CA2402593A1 (en)	2001-09-20
KR100882081B1 (ko)	2009-02-10
CZ20023098A3 (cs)	2003-02-12
CA2402593C (en)	2012-07-03
US6849720B2 (en)	2005-02-01
PL358381A1 (en)	2004-08-09
IL151713A0 (en)	2003-04-10
UA78489C2 (en)	2007-04-10
KR20020089384A (ko)	2002-11-29
IL139217A0 (en)	2001-11-25
EE200200517A (et)	2004-02-16
NO20024223L (no)	2002-10-24
EA200200974A1 (ru)	2003-02-27
YU68602A (sh)	2006-03-03
MXPA02009091A (es)	2005-06-20
PL206041B1 (pl)	2010-06-30
HUP0300142A3 (en)	2005-07-28
AR028518A1 (es)	2003-05-14
HU226194B1 (hu)	2008-06-30
ZA200206654B (en)	2003-10-20
DE60128452D1 (de)	2007-06-28
ATE362490T1 (de)	2007-06-15
HRP20020704A2 (en)	2004-12-31
BG107063A (bg)	2003-05-30
EP1263790B1 (en)	2007-05-16
BG65762B1 (bg)	2009-10-30
PT1263790E (pt)	2007-06-01
NO20024223D0 (no)	2002-09-04
CN1418225A (zh)	2003-05-14
SK13122002A3 (sk)	2003-04-01
NZ520944A (en)	2004-04-30
JP4768193B2 (ja)	2011-09-07
US20030186343A1 (en)	2003-10-02
HK1055750A1 (en)	2004-01-21
AU2001241002B8 (en)	2006-05-04
AU4100201A (en)	2001-09-24
HRP20020704B1 (en)	2011-01-31
JP2004506603A (ja)	2004-03-04
EA007494B1 (ru)	2006-10-27
HUP0300142A2 (hu)	2003-06-28
CY1108020T1 (el)	2013-09-04
DE60128452T2 (de)	2007-09-13
SK287348B6 (sk)	2010-08-09
RS51406B (sr)	2011-02-28
SI1263790T1 (sl)	2007-10-31

Publication	Publication Date	Title
CY2019029I2 (el)	2020-05-29	Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
LTC2305817I2 (lt)	2021-04-26	Anti-IL-12 antikūnai, kompozicijos, būdai ir panaudojimas
DK2168984T3 (da)	2012-12-10	Humane antistoffer, som binder humant IL-12, og fremgangsmåder til pro-duktion heraf
AU2002359851A8 (en)	2003-07-30	Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
DK1259547T3 (da)	2012-10-15	Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf
DE60222658D1 (de)	2007-11-08	Monoklonaler anti-cd-40-antikörper
DK1957539T3 (da)	2013-05-06	Humane monoklonale antistoffer til proteintyrosinkinase 7 (ptk7) og deres anvendelse
DK1432735T3 (da)	2012-08-06	Antagonistiske humane anti-htnfsf13b-antistoffer
CY2012019I2 (el)	2015-08-05	Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20
NO20031642D0 (no)	2003-04-10	Humaniserte anti-LT-O-R-antistoff
DK1263790T3 (da)	2007-07-02	Monoklonale antistoffer for den humane LDL-receptor, deres produktionsmetode og anvendelse
NO20032542D0 (no)	2003-06-05	Dempede anti-CD28-antistoffer og anvendelse derav
IL152725A0 (en)	2003-06-24	Human receptor proteins, related reagents and methods
EE200300569A (et)	2004-04-15	CD44v6-spetsiifilised antikehad
AU2002217212A1 (en)	2002-06-18	Method for preparing a human monoclonal antibody, fragments thereof or antibodies comprising such fragments, resulting antibodies and use thereof
FI20011055L (fi)	2002-11-19	Heveiiniä sitovat monoklonaaliset vasta-aineet
ITPD20000192A0 (it)	2000-07-28	Anticorpi policlonali
ATE535259T1 (de)	2011-12-15	Immunogener, monoklonaler antikörper
EE200300377A (et)	2003-10-15	Loomulikud HI-viiruse vastased antikehad
AR028262A1 (es)	2003-04-30	Anticuerpos especificos de fap-alfa humanos
IL135025A0 (en)	2001-05-20	Monoclonal antibodies to the human ldl receptor, their production and use
GB0016824D0 (en)	2000-08-30	Human monoclonal antibodies
GB0017139D0 (en)	2000-08-30	Human monoclonal antibodies
GB0325391D0 (en)	2003-12-03	Human monoclonal antibodies
ATE506966T1 (de)	2011-05-15	Humanisierte super-antikörper